Impact of Morning Symptoms in Clinical Control of Chronic Obstructive Pulmonary Disease (COPD)

Impact of Morning Symptoms in Clinical Control of COPD

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01266395

Acronym

IMPAEPOC

Enrollment

1268

Registered

2010-12-24

Start date

2010-01-31

Completion date

2011-07-31

Last updated

2011-08-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD

Keywords

morning symptoms COPD

Brief summary

Observational study to know the Impact of morning symptoms in clinical control of COPD patients. 1200 patients will be included by General practitioners (GPs) and pneumologists. Objective: establish if there are differences in the impact of COPD on daily activities and morning symptoms measured through questionnaires of daily life activity (Capacity of Daily Living during the Morning (CDLM), Global Chest Symptoms Questionnaire (GCSQ))

Interventions

None listed

Study design

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

40 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patient has signed informed consent form * Patients of both sexes,\> 40 years. * Patients diagnosed with COPD according to global consensus on the definition, classification and management of the disease (GOLD) criteria: * post-bronchodilator forced expiratory volume in 1 s (FEV1) / forced vital capacity (FVC) \<70% * post-bronchodilator FEV1 \<80% (stage II, III and IV)

Exclusion criteria

* Participating in an epidemiological study or clinical trial * Patient with other respiratory disease than COPD (eg bronchial asthma, cystic fibrosis, severe bronchiectasis, restrictive lung disease, cancer, etc.). * Patients with mild COPD: FEV1\> 80%

Design outcomes

Primary

Measure	Time frame	Description
Determine if there are differences in the impact of COPD on patients according to the characteristics of the disease. To measure the impact of specific self-administered questionnaires used in COPD: CDLMQ, GCSQ and CCQ	Retrospective, (previous 24 months)	Capacity of Daily Living during the Morning Qustionnaire (CDLMQ), Global Chest Symptoms Questionnaire (GCSQ)and COPD Control Questionnaire (CCQ)

Secondary

Measure	Time frame
Assess comorbidities as a risk factor for frequent exacerbations	Retrospective, (previous 24 months)

Countries

Spain

Outcome results